Doctor profile · Federal record
Dr. ROBERT KLEIN, MD
Ophthalmology Physician (CMS: OPHTHALMOLOGY) · Specialist · Ophthalmology Physician · NEW YORK, NY
- NPI 1174558639
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 52 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
950 THIRD AVENUE, 3RD FLOOR
NEW YORK, NY 10022
(212) 861-9797
fax (212) 628-0698
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- December 3, 2019
- Year of graduation
- 1974 — 52 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State licenses (3)
- New York #124673-1 · New York #1246732 · New York #124678-1
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1174558639. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,514
Distinct HCPCS
10
Medicare allowed
$944,275
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 2,640 | 11 | $37 | |
92134 |
Imaging of retina | 1,079 | 522 | $45 | |
92012 |
Established patient problem focused exam of visual system | 762 | 318 | $104 | |
92250 |
Photography of the retina | 745 | 482 | $43 | |
J0178 |
Injection, aflibercept, 1 mg | 506 | 45 | $868 | |
76512 |
2d ultrasound scan of eye tissue and structures | 439 | 336 | $73 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 374 | 13 | $228 | |
92014 |
Established patient complete exam of visual system | 365 | 327 | $145 | |
67028 |
Injection of drug into eye | 296 | 63 | $143 | |
92083 |
Exam of visual field with extended testing | 127 | 114 | $73 |
In context: peer comparison
Among 152 peers in this city , average services per provider: 275. This provider delivers 27× the peer median.Open Payments
Industry payments received
All-time total
$763
Transactions
23
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $310.43 | |
| Bausch & Lomb Americas Inc. | 3 | $173.87 | |
| Astellas Pharma US Inc | 3 | $87.31 | |
| ABBVIE INC. | 2 | $50.39 | |
| Tarsus Pharmaceuticals, Inc. | 2 | $42.24 | |
| Genentech USA, Inc. | 1 | $34.10 | |
| Apellis Pharmaceuticals, Inc. | 1 | $34.03 | |
| Alcon Vision LLC | 1 | $16.29 | |
| Dompe US, Inc. | 1 | $14.48 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
602
Patients
280
Total drug cost
$106,400
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Latanoprost | Generic | 135 | 54 | $2,718 |
| Prednisolone Acetate | Generic | 59 | 45 | $3,375 |
| Tobramycin-Dexamethasone (Tobramycin/Dexamethasone) | Brand | 55 | 43 | $4,080 |
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 44 | 40 | $672 |
| Alphagan P (Brimonidine Tartrate) | Brand | 34 | 0 | $11,354 |
| Restasis (Cyclosporine) | Brand | 34 | 12 | $25,964 |
| Timolol Maleate | Generic | 31 | 20 | $587 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 30 | 14 | $710 |
| Xiidra (Lifitegrast) | Brand | 30 | 0 | $26,820 |
| Prolensa (Bromfenac Sodium) | Brand | 27 | 0 | $12,979 |